000893243 001__ 893243
000893243 005__ 20210810182020.0
000893243 0247_ $$2doi$$a10.3389/fneur.2021.680254
000893243 0247_ $$2Handle$$a2128/27972
000893243 0247_ $$2altmetric$$aaltmetric:107709970
000893243 0247_ $$2pmid$$a34220687
000893243 0247_ $$2WOS$$aWOS:000668112300001
000893243 037__ $$aFZJ-2021-02643
000893243 082__ $$a610
000893243 1001_ $$0P:(DE-Juel1)188521$$aHoltbernd, Florian$$b0$$eCorresponding author$$ufzj
000893243 245__ $$aImaging the Pathophysiology of Essential Tremor—A Systematic Review
000893243 260__ $$aLausanne$$bFrontiers Research Foundation$$c2021
000893243 3367_ $$2DRIVER$$aarticle
000893243 3367_ $$2DataCite$$aOutput Types/Journal article
000893243 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1623911266_32701
000893243 3367_ $$2BibTeX$$aARTICLE
000893243 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000893243 3367_ $$00$$2EndNote$$aJournal Article
000893243 520__ $$aBackground: The pathophysiology underlying essential tremor (ET) still is poorly understood. Recent research suggests a pivotal role of the cerebellum in tremor genesis, and an ongoing controversy remains as to whether ET constitutes a neurodegenerative disorder. In addition, mounting evidence indicates that alterations in the gamma-aminobutyric acid neurotransmitter system are involved in ET pathophysiology. Here, we systematically review structural, functional, and metabolic neuroimaging studies and discuss current concepts of ET pathophysiology from an imaging perspective.Methods: We conducted a PubMed and Scopus search from 1966 up to December 2020, entering essential tremor in combination with any of the following search terms and their corresponding abbreviations: positron emission tomography (PET), single-photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), and gamma-aminobutyric acid (GABA).Results: Altered functional connectivity in the cerebellum and cerebello-thalamico-cortical circuitry is a prevalent finding in functional imaging studies. Reports from structural imaging studies are less consistent, and there is no clear evidence for cerebellar neurodegeneration. However, diffusion tensor imaging robustly points toward microstructural cerebellar changes. Radiotracer imaging suggests that the dopaminergic axis is largely preserved in ET. Similarly, measurements of nigral iron content and neuromelanin are unremarkable in most studies; this is in contrast to Parkinson's disease (PD). PET and MRS studies provide limited evidence for cerebellar and thalamic GABAergic dysfunction.Conclusions: There is robust evidence indicating that the cerebellum plays a key role within a multiple oscillator tremor network which underlies tremor genesis. However, whether cerebellar dysfunction relies on a neurodegenerative process remains unclear. Dopaminergic and iron imaging do not suggest a substantial overlap of ET with PD pathophysiology. There is limited evidence for alterations of the GABAergic neurotransmitter system in ET. The clinical, demographical, and genetic heterogeneity of ET translates into neuroimaging and likely explains the various inconsistencies reported.
000893243 536__ $$0G:(DE-HGF)POF4-525$$a525 - Decoding Brain Organization and Dysfunction (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000893243 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000893243 7001_ $$0P:(DE-Juel1)131794$$aShah, N. Jon$$b1$$ufzj
000893243 773__ $$0PERI:(DE-600)2564214-5$$a10.3389/fneur.2021.680254$$gVol. 12, p. 680254$$p680254$$tFrontiers in neurology$$v12$$x1664-2295$$y2021
000893243 8564_ $$uhttps://juser.fz-juelich.de/record/893243/files/fneur-12-680254.pdf$$yOpenAccess
000893243 909CO $$ooai:juser.fz-juelich.de:893243$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000893243 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)188521$$aForschungszentrum Jülich$$b0$$kFZJ
000893243 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131794$$aForschungszentrum Jülich$$b1$$kFZJ
000893243 9130_ $$0G:(DE-HGF)POF3-573$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vNeuroimaging$$x0
000893243 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000893243 9141_ $$y2021
000893243 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-28
000893243 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-28
000893243 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000893243 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT NEUROL : 2019$$d2021-01-28
000893243 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-01-28
000893243 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-01-28
000893243 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-28
000893243 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-01-28
000893243 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-28
000893243 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2021-01-28
000893243 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000893243 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2021-01-28
000893243 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-01-28
000893243 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-28
000893243 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2021-01-28
000893243 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-28
000893243 9201_ $$0I:(DE-Juel1)INM-4-20090406$$kINM-4$$lPhysik der Medizinischen Bildgebung$$x0
000893243 9201_ $$0I:(DE-Juel1)INM-11-20170113$$kINM-11$$lJara-Institut Quantum Information$$x1
000893243 9201_ $$0I:(DE-Juel1)VDB1046$$kJARA-BRAIN$$lJülich-Aachen Research Alliance - Translational Brain Medicine$$x2
000893243 980__ $$ajournal
000893243 980__ $$aVDB
000893243 980__ $$aUNRESTRICTED
000893243 980__ $$aI:(DE-Juel1)INM-4-20090406
000893243 980__ $$aI:(DE-Juel1)INM-11-20170113
000893243 980__ $$aI:(DE-Juel1)VDB1046
000893243 9801_ $$aFullTexts